# Zoetis (ZTS) Forecast Calculator

Interactive five-year financial forecast and DCF for Zoetis. Adjust revenue growth, margins, capex, and WACC to update revenue, free cash flow, and enterprise value.

- Canonical: https://finamodel.com/companies/zoetis/forecast
- Industry: Healthcare
- Forecast start year: 2026

## Historical data

| Year | Revenue | Free cash flow | EBITDA | Net income |
|---:|---:|---:|---:|---:|
| 2021 | 6260000000 | 1335000000 | 2213000000 | 1500000000 |
| 2022 | 6675000000 | 1673000000 | 2437000000 | 1638000000 |
| 2023 | 7776000000 | 1736000000 | 2936000000 | 2037000000 |
| 2024 | 8080000000 | 1326000000 | 3121000000 | 2114000000 |
| 2025 | 8544000000 | 1621000000 | 3427000000 | 2344000000 |

## Frequently asked questions

### What does Zoetis do as an animal health company?

Zoetis is the world's largest animal health company, focused on discovering, developing, manufacturing, and commercializing medicines, vaccines, and diagnostic products. It serves veterinarians, livestock producers, and pet owners across over 100 countries with a business model similar to human pharmaceuticals.

### What are the primary revenue drivers for Zoetis?

Zoetis generates revenue primarily from its United States and International segments, with the U.S. contributing approximately 54% of total revenue. Within these regions, Companion Animal products account for roughly 68% of total revenue, while Livestock products contribute about 31%.

### What is the assumed revenue growth rate in the Zoetis financial model?

The financial model for Zoetis assumes a revenue growth rate of approximately 8.1% for its forecast horizon. This growth, along with margin expansion and cash flow generation, is used to determine the company's equity valuation.

### What is the main purpose of the Zoetis financial model?

The primary purpose of the Zoetis financial model is to forecast the company's revenue growth, margin expansion, and cash flow generation. This analysis is crucial for determining its equity valuation and assessing the long-term earnings impact of its companion animal product pipeline.

### Can I download an Excel financial model for Zoetis?

Yes, an Excel financial model for Zoetis is available for download. This model provides forecasts for the company's performance from FY2026 through FY2030.

### What are Zoetis's capital expenditure plans and assumptions?

Zoetis's financial model assumes capital expenditure as approximately 7.2% of revenue, historically ranging from 5% to 7%. A significant portion, about 60%, is allocated to growth capex, specifically for expanding biological manufacturing capacity in the U.S. and Ireland to support key product rollouts.